What is the long-term trend for Profound Medical's deferred revenue, net of current portion?

Over 2 years (2023 to 2025), Profound Medical's deferred revenue, net of current portion has grown at a -27.0% compound annual growth rate (CAGR), from $728K to $388K.

Profound Medical PROF Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

AmetekAME

$41.8M+5.3%

MicroStrategyMSTR

$5.22M+31.2%

Carrier GlobalCARR

$208M+23.8%

Tesla, Inc.TSLA

$3.85B+6.6%

SolarEdge TechnologiesSEDG

$313.95M+28.9%

General DynamicsGD

$2.39B-12.5%

Other financials

Income statement

See full

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

See full

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

See full

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

See full

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

P/S12.8×-2.8×

Profitability

See full

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

See full

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Profound Medical's deferred revenue, net of current portion?: Profound Medical (PROF) reported deferred revenue, net of current portion of $441K in Q1 2026.
How has Profound Medical's deferred revenue, net of current portion changed year-over-year?: Profound Medical's deferred revenue, net of current portion increased by 418.8% year-over-year, from $85K to $441K.
What is the long-term trend for Profound Medical's deferred revenue, net of current portion?: Over 2 years (2023 to 2025), Profound Medical's deferred revenue, net of current portion has grown at a -27.0% compound annual growth rate (CAGR), from $728K to $388K.